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Abstract
Candida auris is an emerging pathogenic yeast of significant clinical concern because of its frequent intrin-
sic resistance to fluconazole and often other antifungal drugs and the high mortality rates associated with
systemic infections. Furthermore, C. auris has a propensity for persistence and transmission in health care
environments. The reasons for this efficient transmission are not well understood, and therefore we tested
whether enhanced resistance to environmental stresses might contribute to the ability of C. auris to spread
in health care environments. We compared C. auris to other pathogenic Candida species with respect to
their resistance to individual stresses and combinations of stresses. Stress resistance was examined using
in vitro assays on laboratory media and also on hospital linen. In general, the 17 C. auris isolates examined
displayed similar degrees of resistance to oxidative, nitrosative, cationic and cell wall stresses as clinical
isolates of C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. guilliermondii, C. lusitaniae and
C. kefyr. All of the C. auris isolates examined were more sensitive to low pH (pH 2, but not pH 4) compared
to C. albicans, but were more resistant to high pH (pH 13). C. auriswas also sensitive to low pH, when tested
on contaminated hospital linen. Most C. auris isolates were relatively thermotolerant, displaying significant
growth at 47°C. Furthermore, C. auriswas relatively resistant to certain combinations of combinatorial stress
(e.g., pH 13 plus 47°C). Significantly, C. auris was sensitive to the stress combinations imposed by hospital
laundering protocol (pH > 12 plus heat shock at >80°C), suggesting that current laundering procedures are
sufficient to limit the transmission of this fungal pathogen via hospital linen.
Key words: Candida auris, Candida pathogens, stress resistance, decontamination, hospital laundry.
Introduction
A number of Candida species cause infections in humans. These
yeasts are estimated to cause about 400,000 of the estimated
two million life-threatening fungal infections that occur an-
nually worldwide, generally in individuals undergoing surgery
or with severely compromised immune systems.1 Indeed, the
Candida genus is the fourth most common cause of hospital
acquired bloodstream infections (candidemia) and the third
most common cause in intensive care units.2 Historically, the
majority of candidemia cases have been attributed to Candida
albicans.3 However, the frequency of infections caused by
non-Candida albicans Candida (NAC) species is increasing.4,5
The rising proportion of Candida glabrata, Candida krusei
and Candida guilliermondii infections is thought to be due to
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their intrinsic resistance to certain antifungal drugs,6,7 such as
fluconazole, which, when used routinely as a prophylaxis, can
lead to selection of resistant species.8 Meanwhile, the prevalence
of Candida parapsilosis outbreaks in intensive care units and
premature neonates is probably due to this yeast’s effective
adherence to catheters and skin and the lipid rich environment
favorable for its growth afforded by the frequent use of total
parenteral nutrition (TPN) in this group.9
Candida auris has recently emerged as a global health con-
cern.10–12 C. auris was first isolated in South Korea in 1996,
but was not identified as such at the time.13 Although present,
C. auris infections were rare prior to 2009, when it was isolated
from the ear canal of a patient in Japan and described as a new
species.14,15 Evidence forC. auris as a cause of systemic infection
in a health care setting was not documented until 2011 in South
Korea.13 Since then, C. auris has spread around the globe at an
alarming rate. March 2012 saw the first recorded outbreak in
the Americas, in a hospital in Venezuela,16 this was quickly fol-
lowed by the first outbreak in the USA in 2013.16 Sporadic cases
also appeared in the UK from 2013,17 with the first UK out-
break in 2015.18 The propensity of C. auris to cause outbreaks
in health care settings is now a major global health concern.
The rapid emergence of C. auris has caused concern for several
reasons. First, this species exhibits a propensity for patient-to-
patient transmission in care settings, more so than other species
of Candida and other pathogenic fungi.19 Amplified fragment
length polymorphism (AFLP) analysis and genome sequencing
has suggested that outbreak strains are highly clonal within geo-
graphical regions and distinct between continents.18,20,21 Based
on these distinctions, C. auris isolates are considered to rep-
resent four phylogenetic clades,14 but recently a potential fifth
clade has been described.22 Second, a significant proportion ofC.
auris strains display multidrug resistance. Approximately 90%
of C. auris isolates are reported to be resistant to fluconazole,
about 8% are resistant to amphotericin B, about 2% are re-
sistant to echinocandins, and about 25% are resistant to more
than one class of agent,23 with patterns of resistance closely
linked to the phylogenetic clades.24 This drug resistance can
lead to therapeutic failure. Third, in some settings C. auris is
associated with an unusually high mortality rate compared to
other Candida species. For example, whilst C. albicans is associ-
ated with ∼40% mortality in hospital patients,25 the mortality
rate for C. auris in healthcare environments is 30–60%.16,18,26
Fourth, C. auris has proved difficult to identify using standard
biochemical methods and consequently was often misidentified
as other Candida species, particularly Candida haemulonii. This
increased the chance of inappropriate treatment and, as a result,
therapeutic failure.26,27
Currently, C. auris is the focus of a considerable research
effort. This research has revealed that C. auris is closely re-
lated, phylogenetically, to C. krusei, C. haemulonii, and C. lusi-
taniae, all of which have been shown to exhibit resistance to
azoles and/or amphotericin B.14 Genome sequencing combined
with phenotypic analysis has revealed that C. auris shares many
of the virulence factors and fitness attributes of C. albicans,
such as multidrug efflux systems and cell wall remodeling path-
ways.21,26,28 SomeC. auris strains exhibit salt tolerance, thermo-
tolerance up to 42°C, as well as an aggregating phenotype that
has been proposed to contribute to its efficient transmission.28,29
The persistence of C. auris in healthcare settings is also
thought to have contributed to its emergence as a global health
concern. C. auris has been found to particularly colonize the
groin and axilla of infected and noninfected people, it was first
isolated from aural cavities and has also been found colonizing
the nostrils.18,30 C. auris can also persist in patient rooms for
extended periods of time, even after cleaning,31 on mattresses,
chairs, windowsills, and areas around patient’s beds.18,30 Qua-
ternary ammonia products, such as Lysol and Virex II 256, have
been shown to be relatively ineffective in killing C. auris,32 but
evidence suggests that chlorine products are effective,29,33–35
and the Centers for Disease Control and Prevention (CDC)
guidelines recommend use of disinfectants approved for use
against Clostridioides difficile.30
We reasoned that resistance to certain environmental stresses
might contribute to the spread of C. auris in healthcare envi-
ronments. Hence, in this study we compared the stress phenome
of C. auris to those of other pathogenic Candida species
(C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei,
C. guilliermondii, C. lusitaniae, and C. kefyr), revealing sensitiv-
ities to specific combinations of environmental stresses in vitro.
The focus of most disinfection studies to date has been the re-
moval ofC. auris from hard surfaces or the prevention of transfer
between individuals.18,29,33–35 Therefore, we extended our anal-
yses to hospital bed linen, demonstrating that the environmental
stresses imposed during hospital laundry procedures are effective
in killing C. auris, as well as other pathogenic Candida species.
Methods
Candida clinical isolates
Seventeen C. auris isolates from the South Asian, East Asian,
and South Africa clades were selected for analysis (Table 1).
These isolates displayed different drug resistance profiles and
aggregation phenotypes.28 For comparison with other Candida
pathogens, we selected three isolates each of C. albicans, C.
glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. guillier-
mondii, C. lusitaniae, and C. kefyr from the collections of
Donna MacCallum and Frank Odds (University of Aberdeen,
UK) (Table 2). These 17 C. auris isolates and 24 other Candida
isolates were arrayed in a microtiter plate format for stress
resistance assays (Fig. 1).
The identity of the C. auris isolates had been confirmed by
ITS sequence analysis.36,37 To confirm the identity of the other
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Table 1. Candida auris strains.
Mating
Working name Collection name Isolated from Clade Aggregating type Drug resistance Source
auris 1 Gow1715, 470026 blood South Asian a FLZ, CAS 1
auris 2 Gow1716, 470027 blood South Asian a FLZ, VORI, CAS 1
auris 3 Gow1717, 470028 blood South Asian a FLZ, CAS 1
auris 4 Gow1718, 470029 blood South Asian a FLZ, VORI, CAS 1
auris 5 Gow1719, 470030 blood South Asian a FLZ, VORI, CAS 1
auris 6 Gow1720, 470031 blood South Asian a FLZ, CAS 1
auris 7 Gow1721, 470032 blood South Asian a FLZ, CAS 1
auris 8 Gow1722, 470033 blood South Asian a FLZ 1
auris 9 Gow1723, 470034 blood South Asian a FLZ, 5FC 1
auris 10 Gow1725, 470036 blood South Asian a FLZ, CAS, 5FC 1
auris 11 Gow1726, 470037 blood South Asian a FLZ, CAS, 5FC 1
auris 12 Gow1747, NCPF8980#9 blood South African Y α FLZ, CAS 2
auris 13 Gow1748, NCPF8984#15 unknown East Asian Y α FLZ 2
auris 14 Gow1750, NCPF8985#20 wound South Asian a FLZ, ISAV, POSA, VORI, FLY, ANID, CAS 2
auris 15 Gow1749, NCPF13001#16 unknown South Asian a FLZ 2
auris 16 Gow1751, NCPF13005#95 urine South African Y α FLZ, VORI, ANID, AMB, CAS 2
auris 17 VPCI479/P/13 blood South Asian a FLZ 3
Sources: (1) Chakrabarti A. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015; 41: 285–295. doi: 10.1007/s00134-014-
3603-2 (2) Dr. L. Johnson, Public Health England, Bristol (3) Sharma C, Kumar N, Meis JF, Pandey R, Chowdhary A. 2015. Draft genome sequence of a fluconazole-resistant
Candida auris strain from a candidemia patient in India.Genome Announc 3(4): e00722-15. doi:10.1128/genomeA.00722-15.
desorption/ionization time-of-flight mass spectrometry (MALDI
ToF MS)38 and by growth on chromogenic media (BrillianceTM
Candida Agar, Oxoid, Hampshire, UK), which highlighted that
some cultures were mixed. The initial species identification was
confirmed for most isolates (Table 2). However, in a few cases,
initial misidentifications were corrected by MALDI ToF MS: C.
krusei 2 was in fact C. parapsilosis; C. kefyr 2 was C. tropicalis;
and C. parapsilosis 1 was a mixture of C. glabrata and C. tropi-
calis (Table 2; Fig. S1). As strain identification was performed af-
ter the isolates were arrayed, misidentified Candida isolates were
included in the stress panels, below (these are marked with an as-
terisk in the figures).C. krusei 1 and 3 were excluded from some
assays (by washing these wells with 100% ethanol before replica-
tion onto test plates) because these isolates spread and overgrew
neighboring isolates under certain growth conditions.
Candida strains were grown overnight in yeast-extract
peptone dextrose (YPD) (1% yeast extract, 2%mycological pep-
tone, 2% glucose)39 at the specified temperature for each ex-
periment. Similar inocula of each isolate (based on optical den-
sity [OD]600), from early stationary phase liquid cultures, were
aliquoted into a microtiter plate format (Fig. 1), glycerol was
added to a final concentration of 20%,and replicate plates frozen
at −80°C. Plates were then thawed at room temperature for
45 minutes before replica plating onto the specified media.
Stress resistance on plates
To test the stress sensitivity of the Candida isolates, isolates were
replica plated using an 8 × 12 prong replicator (Sigma-Aldrich,
Dorset, UK) onto YPD agar supplemented with one of the fol-
lowing: 1MNaCl; 0.6MKCl; 25mM succinic acid; 25mM suc-
cinic acid plus 5 mM sodium nitrite (NaNO2); 1 mM tert-Butyl
hydroperoxide (t-BOOH); 2.5, 5 or 7.5 mM hydrogen peroxide
(H2O2); 100 μg/ml Calcofluor White (CFW); 100 or 150 μg/ml
Congo Red (CR); or YPD adjusted to pH2, pH4, pH10, pH11,
pH12, or pH13. Plates were incubated at 30°C, 37°C or 47°C
for 24, 48, or 72 hours, as specified. Every experiment included
a control YPD plate incubated at 30°C for 24 hours. Also, clini-
cal isolates were exposed to the following stresses for 10 minutes
in liquid suspension40,41 before plating on YPD: 0.5% chlorhex-
idine (Chlor); 0.5% sodium hypochlorite (NaClO); 2% alcohol
ethoxylate (AlcEth). The growth of each isolate was rated quali-
tatively on a scale of 0 to 3, compared to the growth of the same
isolate on YPD at 30°C in the absence of stress (where ‘normal’
growth was assigned 2, no growth was assigned 0, less growth
was assigned 1, and more growth was assigned 3) (Fig. 1C). The
average from six independent replicate experiments was then cal-
culated to provide a semiquantitative measure of the effect of the
stress upon growth.
Stress resistance on hospital linen
To test the stress sensitivities of Candida clinical isolates on hos-
pital linen, bedsheets were obtained from NHS Grampian, one
of the regional health boards for the National Health Service
Scotland, cut into required sizes and sterilized by autoclaving.
The 41 Candida isolates were replica plated onto 12 × 8 cm
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Figure 1. Comparison of C. auris thermotolerance with other Candida pathogens. (A) The microtiter plate layout of the Candida clinical isolates listed in Tables 1
and 2. Misidentified isolates are highlighted with an asterisk. (B) Growth of Candida isolates for 24 h on YPD agar at the stated temperatures. (C) Illustration of
the semi-quantitative analysis of stress resistance, where 0 = no growth, 1 = less growth, 2 = ‘normal growth’ 3 = more growth, in comparison to the same
isolate grown on YPD at 30°C, using the 47°C panel from (B) which illustrates one representative of six replicates. Data from the six replicate experiments were
used to generate the averages presented in Tables S1 and S2. Note that while ‘C. krusei’ strains were included in the panel (yellow), for technical reasons these
were excluded from our data analysis. This Figure is reproduced in color in the online version ofMedical Mycology.
inoculation, these sheets were laid onto YPD plates containing
different stressors. After incubation for 48 hours at 30°C, the
linen was removed to assess the growth of each isolate. Alter-
natively, where specified, individual Candida isolates were inoc-
ulated onto clean, sterilized 1 × 1 cm squares (approximately
1 × 106 cells per square). To simulate patient soiling, 30 μl of test
soil (Browne washer/disinfector test soil, Serris, France), a sub-
stance used to test washer efficiency bymimicking contamination
by bodily fluids,was added to the squares after inoculation. Inoc-
ulated squares were then laid on YPD plates (containing different
stressors, as above) and incubated at the relevant temperature for
1–3 days. The squares were removed, and cells were recovered by
vigorously vortexing each square in 1 ml sterile water. The cells
were harvested by centrifugation and resuspended in 1 ml water,
then the OD600 of the cell suspension measured to estimate the
amount of Candida recovered after growth on each inoculated
linen square.While the degree of growth in the presence of stress
varied, generally over 95% of those cells harvested after growth
were viable, based on cfu assays.
Results
C. auris isolates generally display similar stress
sensitivities to other Candida species
TheCandida isolates were exposed to a range of individual stress
conditions including growth at different temperatures (ranging
from 30 to 47°C) and pH (2 to 13), cationic stresses (NaCl, KCl),
oxidative stresses (H2O2, t-BOOH), nitrosative stresses (sodium
nitrite), and cell wall stresses (Calcofluor White, Congo Red).
The amount of growth on plates was estimated (Fig. 1), and the
average from six experiments (two technical replicates in each of
three biological repeats) was used to generate a semi-quantitative
measure of the effect of a stress upon growth. These data are
summarized in Table S1.
All of the Candida isolates tested grew well at 30 and 37°C,
but the growth of a subset of C. auris isolates (4–13) was atten-
uated at 42°C and 47°C (Fig. 1B, Table S1). The C. auris isolates
were generally resistant to the cationic, oxidative, nitrosative and
cell wall stresses we examined, with the exception of C. auris 13
and 16 (Fig. 2; Table S1). C. auris 13 and 16 are from the East
Asian and South African clades, respectively. Therefore, their
sensitivities appear to be isolate-, rather than clade-, related. The
stress resistance of most C. auris isolates we examined is con-
sistent with recent data showing that some C. auris isolates are
resistant to double the concentration of CFW and Congo Red
used in this study and to similar levels of cationic and oxidative
stress.42 Furthermore, the C. auris isolates generally displayed
similar levels of resistance to those demonstrated by the other
Candida isolates examined. However, all three C. tropicalis iso-
lates and two C. albicans isolates (2 and 3) were particularly
sensitive to Calcofluor White. Also, C. glabrata was particularly
resistant to H2O2 (Fig. 2; Table S1).
Significant differences in pH tolerance were observed between
species (Fig. 3). C. albicans was tolerant to extremely low pH
(pH 2) as reported previously,43 with C .glabrata and C. guillier-
mondii displaying similar degrees of acid tolerance. Interestingly,
all C. auris isolates were unable to grow at acidic pH (pH 2)
but, with the exception of isolates 13 and 16, were resistant to
highly alkaline conditions (pH 13) (Fig. 3). Therefore, like other
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Figure 2. Resistance of C. auris and other Candida pathogens to individual environmental stresses. (A) The layout of the Candida clinical isolates to facilitate
interpretation. (B) Growth of these Candida clinical isolates on YPD at 30°C for 24 h in the presence of the following stressors: no stress, control; 0.6 M KCl; 1 M
NaCl; 100 μg/ml Calcofluor White, CFW; 150 μg/ml Congo Red; 7.5 mMH2O2; 1 mM t-BOOH); 25 mM succinic acid plus 5 mMNaNO2. Illustrates one representative
of six replicates. This Figure is reproduced in color in the online version ofMedical Mycology.
unlike most of the other species tested, it can grow at the high pH
associated with detergents used during hospital laundering.44
C. auris isolates and other Candida isolates are
sensitive to certain combinatorial stresses
C. albicans and C. glabrata are sensitive to certain combinations
of stress, notably salt plus oxidative stress.45 Therefore, we com-
pared the resistance of the Candida isolates to certain types of
combinatorial stress, focusing initially on combinations of salt
stress with those stresses to which some sensitivity had been ob-
served, as described in the section above. We found that, un-
like C. albicans,46 C. auris isolates were relatively resistant to
the combinatorial salt plus oxidative stress (Table S2). C. para-
psilosis and C. guilliermondii were also resistant to this com-
binatorial stress, whereas C. lusitaniae and C. kefyr were sen-
sitive (Table S2). Interestingly, all of the pathogenic Candida
species tested were sensitive to combinations of NaCl with pH
extremes, whether at pH 2 or pH 13 (Figs 4, 5), and where resid-
ual growth was observed at 30°C, all growth was inhibited when
the temperature was raised to 47°C (Table S1). Therefore, com-
binatorial salt plus pH plus thermal stresses are particularly ef-
fective at killing C. auris and other pathogenic Candida species
(Fig. 4).
Stress resistance of Candida clinical isolates
on hospital linen
It has been suggested that, in the hospital setting, C. auris might
spread via contaminated fomites, such as bed linen.18,30,47 There-
fore, we tested the stress sensitivities of the Candida isolates
when they were contaminating hospital linen under controlled
laboratory conditions. All of the isolates were inoculated onto
linen squares, dried for 1 hour, laid on a YPD plate inoculated
side up, and incubated at 30°C for 72 hours. The linen was then
removed and the plate photographed (Fig. 6A), showing that
most isolates remained viable and were able to grow under these
conditions. However, despite testing a number of approaches,
our attempts to quantify the degree to which each Candida
isolate grew on the linen over YPD plates proved fruitless. The
challenges were compounded by the aggregation phenotype of
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Figure 3. Resistance of the C. auris and other Candida isolates to pH stresses. (A) The layout of the Candida clinical isolates. (B) Growth of these Candida clinical
isolates on YPD at 30°C for 24 h at the specified pH. Illustrates one representative of six replicates. This Figure is reproduced in color in the online version of
Medical Mycology.
Figure 4. Resistance of the Candida isolates to combinations of salt, thermal and acid stress. (A) The layout of the Candida clinical isolates. (B) Growth of these
Candida clinical isolates for 24 h at 30°C on unbuffered YPD (control) or, where specified, at pH2 with 1 M NaCl, or at 47°C. This Figure is reproduced in color in
the online version ofMedical Mycology.
individual isolates on linen squares by resuspending the cells in
water and measuring the resultant OD600.
Using this approach, we focused on five representative iso-
lates: C. albicans SC5314 and C. auris isolates 12, 13, 15, and
16. First we examined them on ‘clean’ linen. The growth of three
C. auris isolates (13, 15, 16) was attenuated at pH2 and none of
these isolates were particularly affected by the salt stress, but the
growth of all five isolates was inhibited by the combination of
these two stresses (Fig. 6B). These data suggest that, for these
Candida isolates, growth on linen does not confer resistance to
combinatorial acid plus salt stress.
We then examined the impact of soiling upon the stress sen-
sitivities of the Candida isolates on linen. Soiling enhanced the
resistance of most clinical isolates to pH2 and/or salt stress,
but particularly to combinatorial salt plus acid stress (Fig. 6C).
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Figure 5. Resistance of the Candida isolates to combinations of salt, thermal and alkaline stress. (A) The layout of the Candida clinical isolates. (B) The growth
of these Candida clinical isolates for 24 hours at 30°C on unbuffered YPD (control) or, where specified, at pH 13, with 1 M NaCl, or at 47°C. Illustrates one
representative of six replicates. This Figure is reproduced in color in the online version ofMedical Mycology.
Figure 6. Resistance of the C. auris to combinations of salt and pH stress when contaminating ‘clean’ or ‘soiled’ hospital linen. (A) The layout of the Candida
clinical isolates and their growth on YPD after contamination of clean linen. (B) Growth of selected clinical isolates on clean 1 × 1 cm linen squares in YPD in
the presence or absence of stress (pH2 and/or 1 M NaCl) for 24 h at 30°C: C. albicans SC5314, SC; C. auris clinical isolates 12, 13, 15, 16. Growth was estimated
by re-suspending the Candida cells in H2O and measuring the OD600/ml. (C) The resistance of these Candida isolates to combinations of acid and salt stress
on soiled linen. Means and standard deviations from three independent replicate experiments are shown, and stressed isolates were compared to the relevant
unstressed control using the student t-test: ns, not significant; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001. This Figure is reproduced in color in the
online version ofMedical Mycology.
Candida resistance to clinically relevant disinfectants
and laundry conditions
Next we examined the impact of clinically relevant disinfectants
and laundry conditions upon the full set of 41 Candida iso-
lates. We tested the susceptibility of these isolates to chlorhex-
idine and sodium hypochlorite as these are frequently used to
clean surfaces in patient rooms.40,41,48,49 The isolates were ex-
posed to 0.5% chlorhexidine or sodium hypochlorite for 10min-
utes before plating.These concentrations were based on standard
cleaning recommendations and previous studies.29,32,41,50,51 All
Candida isolates were sensitive to chlorhexidine and sodium
hypochlorite under these conditions (Fig. 7B).
We also examined the effects of alcohol ethoxylate on the
Candida isolates as this is the primary ingredient in detergents
used in National Health Service (NHS) Scotland laundries (Der-
masil Plus). The alcohol ethoxylate concentration we used (2%)
was based on information provided by the Laundry Facility
at the Foresterhill Healthcare Campus, NHS Grampian. Many
of the clinical isolates, and most of the C. auris isolates in
particular, were resistant to alcohol ethoxylate at 30°C (Fig. 7B).
However, hospital laundry conditions also include rapid cycles
of washing at high temperatures. For example, during the
laundry process at the Foresterhill Healthcare Campus, the
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Figure 7. Resistance of the Candida isolates to hospital laundry-related environmental stresses. (A) The layout of the Candida clinical isolates. (B) The growth
of these Candida clinical isolates for 24 h at 30°C on YPD after exposure to 0.5% chlorhexidine, 0.5% sodium hypochlorite (NaClO) or 2% alcohol ethoxylate for
10 min, or to the specified heat shock (HS) for 5 min. Illustrates one representative of six replicates. This Figure is reproduced in color in the online version of
Medical Mycology.
Figure 8. Resistance of the C. auris to a combination of laundry-related stresses on ‘clean’ or ‘soiled’ hospital linen. (A) The resistance of selected Candida isolates
on clean linen to a combination of alkaline stress (pH12), alcohol ethoxylate (2%) and heat shock (84°C): C. albicans SC5314, SC; C. auris clinical isolates 12, 13,
15, 16. (B) Resistance of the same isolates on soiled linen to a combination of alkaline stress, alcohol ethoxylate and heat shock. Means and standard deviations
from three independent replicate experiments are shown, and stressed isolates were compared to the relevant unstressed control using the student t-test: ns,
not significant; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001. This Figure is reproduced in color in the online version ofMedical Mycology.
to 81°C, 84°C, and 80°C. Each load spends at least 4.5 min
above 80°C. Therefore, we tested the effects of a 5-min heat
shock at different temperatures on the Candida isolates. Heat
shock at 60°C or above killed all of the isolates examined
(Fig. 7B).
We extended our analyses to hospital linen. We included al-
kaline pH because hospital laundry cycles can approach pH12.
Consistent with our earlier finding (Fig. 5),C. auris isolates were
resistant to pH12 when contaminating hospital linen (Fig. 8).
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(84°C) was particularly effective at killing cells on ‘clean’ linen
(Fig. 8A). However, some residual cells were observed on ‘soiled’
linen (Fig. 8B). We conclude that, while care might be required
for badly soiled linen, hospital laundry conditions effectively kill
the pathogenic Candida species we examined, including C. auris.
Discussion
The pathogenic yeasts, C. albicans and C. glabrata, display rela-
tively high levels of resistance to certain environmental stresses
compared to less-pathogenic yeasts, such as C. lusitaniae, and
this is thought to enhance their pathogenicity.52,53 We reasoned
therefore that the ability ofC. auris to persist in hospital environ-
ments and on individuals might be attributed, at least in part, to
a relatively high resistance to environmental stresses compared
with other Candida pathogens. With a view to obtaining a gen-
eral, rather than an isolate-specific, view of their stress phenomes,
17 different C. auris isolates from different geographical loca-
tions were compared with at least two clinical isolates each of
C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. guillier-
mondii, C. lusitaniae, and C. kefyr.
Initially, we examined resistance to a range of individual en-
vironmental stresses. Few significant differences were observed
between C. auris and the other Candida pathogens with respect
to their thermotolerance or their resistance to salt, oxidative, ni-
trosative or cell wall stresses. This is consistent with a recent
study that describes the importance of the stress activated pro-
tein kinase, Hog1, in mediating the resistance of C. auris to such
stresses.42 Similar to other Candida isolates examined, C. auris
isolates were tolerant over a broad pH range. However, C. au-
ris was more resistant under alkaline conditions relative to C.
albicans and C. glabrata (pH13). This is significant because hos-
pital bleach is typically only pH12, and the activity range for
quaternary ammonia products commonly used in health care en-
vironments is between pH3 and pH10.54 It has been reported
that C. auris is less susceptible than C. albicans to 2% and 4%
chlorhexidine55 and that C. parapsilosis, which has shown simi-
lar persistence levels on skin and environmental surfaces,56 is not
killed by chlorine based cleaners after standard exposure times.
In our hands, none of the Candida isolates grew after exposure
to bleach or chlorhexidine in vitro. This confirmed and extended
the findings of a recent report showing that C. auris, C. albicans,
and C. glabrata are sensitive to sodium hypochlorite.34,35,55,57,58
However, it should be noted that, even after repeated application
of chlorhexidine (a common skin disinfectant also used to dis-
infect surgical instruments), C. auris can still persist on patient
skin.18,34,59 It has also been shown that C. auris can persist on
hospital linen for several days.60 This suggests that sensitivity of
C. auris to disinfection depends on the physical and physiologi-
cal context.
We also examined combinatorial stresses because C. albicans
is particularly sensitive to combinations of salt plus oxidative
stress.46 We found that theC. auris isolates displayed similar sen-
sitivity to combinations of salt, alkaline and thermal stress as the
other Candida isolates we examined. Therefore, in general, our
analyses of individual and combinatorial stresses did not sup-
port our initial working hypothesis that persistence of C. auris
is attributable to high levels of environmental stress resistance
compared to other Candida pathogens. The possible exception
was the resistance of C. auris to combinatorial salt plus oxida-
tive stress which could, in principle, compromise the ability of
innate immune cells to kill this fungus.46 However, we reasoned
that this would be unlikely to directly affect the transmission of
C. auris in hospital settings.
Having examined C. auris and other Candida pathogens in
vitro, we then tested the stress resistance of this pathogen when
contaminating hospital linen. In general, the results were simi-
lar to those observed in vitro, where most C. auris isolates re-
mained sensitive to combinatorial salt plus acid stress and the
combination of alkali, alcohol ethoxylate and heat shock. How-
ever, the soiling of linen appeared to enhance resistance to these
stresses. This observation, which is highly relevant to the clini-
cal setting, strengthens the suggestion that the stress sensitivities
of C. auris depends on the physiological context (above). For
example, it is entirely conceivable that C. auris stress resistance
might be enhanced during growth in mixed-species populations
or biofilms.29 This would certainly be consistent with the fact
that the growth conditions significantly affect the responses of
C. albicans to environmental stresses.61–63
We also examined environmental stresses of direct relevance
to hospital laundering, alcohol ethoxylate, thermal and alka-
line stresses. Our data suggest that the heat shocks imposed
during the laundry process promote the killing of the Candida
pathogens we tested. However, it should be noted that our data
do not exclude the possibility that nongrowing persister cells
may survive these treatments.59 Furthermore, particular care
might need to be taken with the washing process for heavily
soiled laundry, as there appears to be an increased level of cells
present on soiled linen after exposure to laundry conditions,
compared to that of clean linen.
In conclusion, the profiles of Candida stress resistance ob-
served in this study do not support our original working hy-
pothesis that the nosocomial transmission of C. auris isolates
is enhanced by their relatively high resistance to environmen-
tal stresses. Nevertheless, it would be prudent to test whether
the stress resistance of Candida species, and C. auris in par-
ticular, is affected by other fabrics found in health care envi-
ronments, such as healthcare professionals’ uniforms, some of
which are washed by these professionals at home. This informa-
tion, together with more accurate replication of the laundry pro-
cess in vitro,would help to inform hospital laundering protocols
in general.
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